Adenylyl cyclase-cyclicAMP signaling in mood disorders: Role of the crucial phosphorylating enzyme protein kinase A

Neuropsychiatric Disease and Treatment

Volumn 4, Issue 1 A, 2008, Pages 161-176

  Dwivedi, Yogesh ^a   Pandey, Ghanshyam N ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

BDNF; Bipolar disorder; CREB; Protein kinase A; Rap 1; Unipolar depression

Indexed keywords

ADENYLATE CYCLASE; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; RAP1 PROTEIN;

BIPOLAR DISORDER; CATALYSIS; CORTICOSTEROID RELEASE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LEARNED HELPLESSNESS; MAJOR DEPRESSION; MOOD DISORDER; NERVE CELL DIFFERENTIATION; NEUROBIOLOGY; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 41549090857     PISSN: 11766328     EISSN: None     Source Type: Journal    
DOI: 10.2147/ndt.s2380     Document Type: Review

References (151)

1. Akin D, Manier DH, Sanders-Bush E, et al. 2005. Signal transduction abnormalities in melancholic depression. Int J Neuropsychopharmacology, 8:5:16.
2. Altar CA, Whitehead RE, Chen R, et al. 2003. Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol Psychiatry, 54:703-9.
3. Angelucci F, Mathe AA, Aloe L. 2000. Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration. J Neurosci Res, 60:783-94.
4. Barbany G, Persson H. 1992. Regulation of neurotrophin mRNA expression in the rat brain by glucocorticoids. Eur J Neurosci, 4:396-403.
5. Beebe SJ. 1994. The cAMP-dependent protein kinases and cAMP signal transduction. Semin Cancer Biol, 5:285-94.
6. Belmaker RH, Zohar J, Ebstein RP. 1980. Cyclic nucleotides in mental disorder. Adv Cyclic Nucleotide Res, 12:187-98.
7. Benes FM, Vincent SL, Todtenkopf M. 2001. The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol Psychiatry, 50:395-406.
8. Berrettini WH, Cappellari CB, Numberger JI, et al. 1987. β-adrenergic receptors on lymphoblasts. A study of manic-depressive illness. Neuropsychobiology, 17:15-8.
9. Berruti G. 2003. cAMP activates Rap1 in differentiating mouse male germ cells: a new signaling pathway mediated by the cAMP-activated exchange factor Epac? Cell Mol Biol, 49:381-8.
10. Bornfeldt KE, Krebs EG. 1999. Crosstalk between protein kinase A and growth factor receptor signaling pathways in arterial smooth muscle. Cell Signal, 11:465-77.
11. Borrelli E, Mommayeur JP, Foulkes NS, et al. 1992. Signal transduction and gene control: The cAMP pathway. Crit Rev Oncog, 3:321-38.
12. Bos JL, de Rooij J, Reedquist KA. 2001. Rapt signalling: adhering to new models. Nat Rev Mol Cell Biol, 2:369-77.
13. Brandon EP, Logue SF, Adams MR, et al. 1998. Defective motor behavior and neural gene expression in RIIβ-protein kinase A mutant mice. J Neurosci, 18:3639-49.
14. Brown ES, Rush AJ, McEwen BS. 1999. Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. Neuropsychopharmacology, 21:474-84.
15. Bugrim AE. 1999. Regulation of Ca2+ release by cAMP-dependent protein kinase A mechanism for agonist-specific calcium signaling?. Cell Calcium, 25:219-26.
16. Chang A, Li PP, Warsh JJ. 2003a. Altered cAMP-dependent protein kinase subunit immunolabeling in postmortem brain from patients with bipolar affective disorder. J Neurochem, 84:781-91.
17. Chang A, Li PP, Warsh JJ. 2003b. cAMP-dependent protein kinase (PKA) subunit mRNA levels in postmortem brain from patients with bipolar affective disorder (BD). Mol Brain Res, 116:27-37.
18. Chen AC, Shirayama Y, Shin KH, et al. 2001. Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect. Biol Psychiatry, 49:753-62.
19. Chen B, Dowlatshahi D, MacQueen GM, et al. 2001. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry, 50:260-5.
20. Chen B, Wang JF, Hill BC, et al. 1999. Lithium and valproate differentially regulate brain regional expression of phosphorylated CREB and c-Fos. Mol Brain Res, 70:45-53.
21. Cho-Chung YS. 1990. Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy. Cancer Res, 50:7093-100.
22. Clegg CH, McKnight GS. 1988. Genetic characterization of a brain-specific form of the type I regulatory subunit of cAMP-dependent protein kinase. Proc Natl Acad Sci USA, 85:3703-7.
23. Constantinescu A, Gordon AS, Diamond I. 2002. cAMP-dependent protein kinase types I and II differentially regulate cAMP response element-mediated gene expression. J Biol Chem, 277:18810-6.
24. de Rooij J, Zwartkruis FJ, Verheijen MH, et al. 1998. Epac is a Rapt guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature, 396:474-7.
25. Dowlatshahi D, MacQueen GM, Wang JF, et al. 1999. Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet, 352:1754-5.
26. Drugan JK, Rogers-Graham K, Gilmer T, et al. 2000. The Ras/p120 GTPase-activating protein (GAP) interaction is regulated by the p120 GAP pleckstrin homology domain. J Biol Chem, 275:35021-7.
27. Duman RS, Heninger GR, Nestler EJ. 1997. A molecular and cellular theory of depression. Arch Gen Psychiatry, 54:597-606.
28. Duman RS, Malberg J, Nakagawa S, et al. 2000. Neuronal plasticity and survival in mood disorders. Biol Psychiatry, 48:73 2-9.
29. Duman RS. 2002. Structural alterations in depression: cellular mechanisms underlying pathology and treatment of mood disorders. CNS Spectr, 7:140-2.
30. Dwivedi Y, Conley RR, Roberts RC, et al. 2002a. [3H]cAMP binding sites and protein kinase A activity in the prefrontal cortex of suicide victims. Am J Psychiatry, 159:66-73.
31. Dwivedi Y, Mondal AC, Rizavi HS, et al. 2006. Differential and brain region-specific regulation of Rap-1 and Epac in depressed suicide victims. Arch Gen Psychiatry, 63:639-48.
32. Dwivedi Y, Mondal AC, Shukla PK, et al. 2004b. Altered protein kinase A in brain of learned helpless rats: effects of acute and repeated stress. Biol Psychiatry, 56:30-40.
33. Dwivedi Y, Pandey GN. 2000. Adrenal glucocorticoids modulate [3H]cyclic AMP binding to protein kinase A (PKA), cyclic AMP-dependent PKA activity, and protein levels of selective regulatory and catalytic subunit isoforms of PKA in rat brain. J Pharmacol Exp Ther, 294:103-6.
34. Dwivedi Y, Rao JS, Rizavi HS, et al. 2003a. Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects. Arch Gen Psychiatry, 60:273-82.
35. Dwivedi Y, Rizavi HS, Conley RR, et al. 2002b. mRNA and protein expression of selective alpha subunits of G proteins are abnormal in prefrontal cortex of suicide victims. Neuropsychopharmacology, 27:499-517.
36. Dwivedi Y, Rizavi HS, Conley RR, et al. 2003b. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry, 60:804-15.
37. Dwivedi Y, Rizavi HS, Shukla PK, et al. 2004a. Protein kinase A in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits. Biol Psychiatry, 55:234-43.
38. Ebstein RP, Lerer B, Shapira B, et al. 1988. Cyclic AMP second-messenger signal amplification in depression. Br J Psychiatry, 152:665-9.
39. Extein I, Tallman J, Smith CC, et al. 1979. Changes in lymphocyte beta-adrenergic receptors in depression and mania. Psychiatry Res, 1:191-7.
40. Fields A, Li PP, Kish SJ, et al. 1999. Increased cyclic AMP-dependent protein kinase activity in postmortem brain from patients with bipolar affective disorder. J Neurochem, 73:1704-10.
41. Fimia GM, Sassone-Corsi P. 2001. Cyclic AMP signaling. J Cell Sci, 114:1971-2.
42. Finkbeiner S. 2000. Calcium regulation of the brain-derived neurotrophic factor gene. Cell Mol Life Sci, 57:394-401.
43. Francis SH, Corbin JD. 1999. Cyclic nucleotide-dependent protein kinases: intracellular receptors for cAMP and cGMP action. Crit Rev Clin Lab Sci, 36:275-328.
44. Fukumoto T, Morinobu S, Okamoto Y, et al. 2001. Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology, 158:100-6.
45. Hattori M, Minato N. 2003. Rap1 GTPase: functions, regulation, and malignancy. J Biochem, 134:479-84.
46. Healy D, Carney PA, Leonard BE. 1993. Monoamine-related markers of depression - changes following treatment. J Psychiatr Res, 17:251-60.
47. Hirschfeld RM, Weissman MM. 2002. Risk factors for major depression and bipolar disorder In Davis KL, Charney D, Coyle JT, Nemeroff C (eds). Neuropsychopharmacology - the fifth generation of progress. Philadelphia: Lippincott Williams and Wilkins p 1017-25.
48. Huang EJ, Reichardt LF. 2001. Neurotrophins: Roles in neuronal development and function. Annu Rev Neurosci, 24:677-736.
49. Jans LAW, Riedel WJ, Markus CR, et al. 2007. Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. Mol Psychiatry, 12:522-43.
50. Jeanningros R, Mazzola P, Azorin JM, et al. 1991. β-adrenoceptor density of intact mononuclear leukocytes in subgroups of depressive disorders. Biol Psychiatry, 29:789-98.
51. Jordan JD, Landau EM, Iyengar R. 2000. Signaling networks: the origins of cellular multitasking. Cell, 103:193-200.
52. Kanof PD, Coccaro EF, Johns CA, et al. 1989. Cyclic-AMP production by polymorphonuclear leukocytes in psychiatric disorders. Biol Psychiatry, 25:413-20.
53. Kanof PD, Johns C, Davidson M, et al. 1986. Prostaglandin receptor sensitivity in psychiatric disorders. Arch Gen Psychiatry, 43:987-93.
54. Kanof PD, Johns CA, Davidson M, et al. 1988. Platelet alpha2-adrenergic receptor function in psychiatric disorders. Psychiatry Res, 23:11-22.
55. Karege F, Perret G, Bondolfi. G, et al. 2002b. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res, 109:143-8.
56. Karege F, Schwald M, Cisse M. 2002a. The cAMP-PKA activity and BDNF expression in lymphoblast cells of bipolar disorder patients. Int J Neuropsychopharmacol, 5:S59.
57. Karege F, Schwald M, Papadimitriou P, et al. 2004. The cAMP-dependent protein kinase A and brain-derived neurotrophic factor expression in lymphoblast cells of bipolar affective disorder. J Affect Disord, 79:187-92.
58. Kay G, Sargeant M, McGuffin P, et al. 1993. The lymphoblast beta-adrenergic receptor in bipolar depressed patients: characterization and down-regulation. J Affect Disord, 27:163-72.
59. Kessler RC, McGonagle KA, Zhao S, et al. 1994. Lifetime and 12-month prevalence of DSM-II1-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry, 51:8-19.
60. Kitayama H, Sugimoto Y, Matsuzaki T, et al. 1989. A ras-related gene with transformation suppressor activity. Cell, 56:77-84.
61. Klysner R, Geisler A, Rosenberg R. 1987. Enhanced histamine and beta-adrenoreceptor-mediated cyclic AMP formation in leukocytes from patients with endogenous depression. J Affect Disord, 13:227-32.
62. Koch JM, Kell S, Hinze-Selch D, et al. 2002. Changes in CREB-phosphorylation during recovery from major depression. J Psychiatr Res, 36:369-75.
63. Landmark BF, Oyen O, Skalhegg BS, et al. 1993. Cellular localization and age-dependent changes of the regulatory subunits of cAMP-dependent protein kinase in rat testis. J Reprod Fertil, 99:323-34.
64. Lara J, Kusano K, House S, et al. 2003. Interactions of cyclic adenosine monophosphate, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor treatment on the survival and growth of postnatal mesencephalic dopamine neurons in vitro. Exp Neurol, 180:32-45.
65. Li M, Wang X, Meintzer MK, et al. 2000. Cyclic AMP promotes neuronal surival by phosphorylation of glycogen synthase kinase 3β. Mol Cell Biol, 20:9356-63.
66. Liesi P, Rechardt L, Wartiovaara J. 1983. Nerve growth factor induces adrenergic neuronal differentiation in F9 teratocarcinoma cells. Nature, 306:265-7.
67. Lindeforts N, Brodin E, Metsis M. 1995. Spatiotemporal selective effects on brain-derived neurotrophic factor and trkB messenger RNA in rat hippocampus by electroconvulsive shock. Neuroscience, 65:661-70.
68. Liu M, Simon MI. 1996. Regulation by cAMP-dependent protein kinase of a G-protein-mediated phospholipase C. Nature, 382:83-7.
69. Ludvig N, Ribak CE, Scott JD, et al. 1990. Immunocytochemical localization of the neural-specific regulatory subunit of the type II cyclic AMP-dependent protein kinase to postsynaptic structures in the rat brain. Brain Res, 520:90-102.
70. Maj M, Ariano MG, Arena F, et al. 1984. Plasma cortisol, catecholamine and cyclic AMP levels, response to dexamethasone suppression test and platelet MAO activity in manic-depressive patients. A longitudinal study. Neuropsychobiology, 11:168-73.
71. Manier DH, Eiring A, Shelton RC, et al. 1996. (-adrenoceptor-linked protein kinase A (PKA) activity in human fibroblasts from normal subjects and from patients with major depression. Neuropsychopharmacology, 15:555-61.
72. Manier DH, Shelton RC, Ellis TC, et al. 2000. Human fibroblasts as a relevant model to study signal transduction in affective disorders. J Affect Disord, 61:51-8.
73. Mann JJ, Brown RP, Halper JP, et al. 1985. Reduced sensitivity of lymphocyte beta-adrenergic receptors in patients with endogenous depression and psychomotor agitation. N Eng J Med, 313:715-20.
74. Marshall R, Dragunow M. 2000. Is CREB a key to neuronal survival? Trends Neurosci, 23:48-53.
75. Matsushita M, Nairn AC. 1999. Inhibition of the Ca2+/ calmodulin-dependent protein kinase I cascade by cAMP-dependent protein kinase. J Biol Chem, 274:10086-93.
76. McEwen BS. 1999. Stress and hippocampal plasticity. Annu Rev Neurosci, 22:105-22.
77. Meredith G, Callen S, Scheuer D. 2002. Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration. Brain Res, 949:219-27.
78. Miguel-Hidalgo JJ, Rajkowska G. 2002. Morphological brain changes in depression. Can antidepressants reverse them? Curr Opin, 16:361-72.
79. Montminy MR, Gonzalez GA, Yamamoto KK. 1990. Regulation of cAMP-inducible genes by CREB. Trends Neurosci, 13:184-8.
80. Moore AN, Waxham MN, Dash PK. 1996. Neuronal activity increases the phosphorylation of the transcription factor cyclic AMP response element binding protein (CREB) in rat hippocampus and cortex. J Biol Chem, 271:14214-20.
81. Murphy DL, Donnelly C, Moskowitz J. 1974. Catecholamine receptor functions in depressed patients. Am J Psychiatry, 131:13 89-94.
82. Nakata K, Ujike H, Sakai A, et al. 2003. Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci Lett, 337:17-20.
83. Nestler EJ, Greengard P. 1994. Protein phosphorylation and the regulation of neuronal function In Siegel GJ, Albers RW, Agranoff BW, Molinoff P (eds). Basic neurochemistry: molecular, cellular, and medical aspects. Boston: Little Brown p 449-74.
84. Neves-Pereira M, Mundo E, Muglia P, et al. 2002. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet, 71:651-5.
85. Nibuya M, Morinobu S, Duman RS. 1995. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci, 15:7539-47.
86. Nibuya M, Nestler EJ, Duman RS. 1996. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci, 16:2365-72.
87. Odagaki Y, Garcia-Sevilla JA, Huguelet P. 2001. Cyclic AMP-mediated signaling components are upregulated in the prefrontal cortex of depressed suicide victims. Brain Res, 898:224-31.
88. Oyen O, Sandberg M, Eskild W, et al. 1988. Differential regulation of messenger ribonucleic acids for specific subunits of cyclic adenosine 3′, 5′-monophosphate (cAMP)-dependent protein kinase by cAMP in rat Sertoli cells. Endocrinology, 122:2658-66.
89. Pacheco MA, Stockmeier C, Meltzer HY, et al. 1996. Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain. Brain Res, 723:37-45.
90. Pandey GN, Dysken MW, Garver DL, et al. 1979. Beta-adrenergic receptor function in affective illness. Am J Psychiatry, 136:675-8.
91. Peet M, Peters S. 1995. Drug-induced mania. Drug Saf, 12:146-53.
92. Perez J, Tardito D, Mori S. 1999. Abnormalities of cyclic adenosine monophosphate signaling in platelets from untreated patients with bipolar disorder. Arch Gen Psychiatry, 56:248-53.
93. Perez J, Tardito D, Mori S, et al. 2000. Altered Rap1 endogenous phosphorylation and levels in platelets from patients with bipolar disorder. J Psychiatr Res, 34:99-104.
94. Perez J, Tardito D, Racagni G. 2001. Protein kinase A and Rap1 levels in platelets of untreated patients with major depression. Mol Psychiatry, 6:44-9.
95. Perez J, Zanardi R, Mori S. 1995. Abnormalities of cAMP-dependent endogenous phosphorylation in platelets from patients with bipolar disorder. Am J Psychiatry, 152:1204-6.
96. Petty F, Sherman AD. 1979. Reversal of learned helplessness by imipramine. Commun Psychopharmacol, 3:371-3.
97. Post RK Gold P, Rubinow DR, et al. 1982. Peptides in the cerebrospinal fluid of neuropsychiatric patients: an approach to central nervous system peptide function. Life Sci, 31:1-15.
98. Qi M, Zhuo M, Skalhegg BS, et al. 1996. Impaired hippocampal plasticity in mice lacking the Cβ catalytic subunit of cAMP-dependent protein kinase. Proc Natl Acad Sci U S A, 93:1571-6.
99. Rahman S, Li PP, Young LT. 1997. Reduced [3H]cyclic AMP binding in postmortem brain from subjects with bipolar affective disorder. J Neurochem, 68:297-304.
100. Rajkowska. G. 2002. Cell pathology in mood disorders. Semin Clin Neuropsychiatry, 7:281-92.
101. Rajkowska G. 2000. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry, 48:766-7.
102. Rao JS, Bazinet RP, Rapoprt SI, Lee HJ. 2007. Chronic administration of carbamazepine downregulates AP-2 DNA-binding activity and AP-2alpha protein expression in rat frontal cortex. Biol Psychiatry, 61:154-61.
103. Rao JS, Ertley RN, Lee HJ, DeMar JC Jr, Arnold JT, Rapoport SI, Bazinet RP. 2007. n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol Psychiatry, 12:36-46.
104. Reiach JS, Li PP, Warsh JJ. 1999. Reduced adenylyl cyclase immunolabeling and activity in postmortem temporal cortex of depressed suicide victims. J Affect Disord, 56:141-51.
105. Riccio A, Ahn S, Davenport CM, et al. 1999. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science, 286:2358-61.
106. Rydel RE, Greene LA. 1988. cAMP analogs promote survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor. Proc Natl Acad Sci USA, 85:1257-61.
107. Sapolsky RM. 1996. Stress, glucocorticoids and damage to the nervous system: the current state of confusion. Stress, 1:1-11.
108. Sapolsky RM. 2000. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry, 49:755-65.
109. Sarkar D, Erlichman J, Rubin CS. 1984. Identification of a calmodulin-binding protein that co-purifies with the regulatory subunit of brain protein kinase II. J Biol Chem, 259:9840-6.
110. Seligman ME, Maier SF. 1967. Failure to escape traumatic shock. J Exp Psychol, 74:1-9.
111. Scott JD, Glaccum MB, Zoller MJ, et al. 1987. The molecular cloning of a type II regulatory subunit of the cAMP-dependent protein kinase from rat skeletal muscle and mouse brain. Proc Natl Acad Sci USA, 84:5192-6.
112. Scott JD, Stofko RE, McDonald JR et al. 1990. Type II regulatory subunit dimerization determines the subcellular localization of the cAMP-dependent protein kinase. J Biol Chem, 265:21561-6.
113. Sen S, Nesse RM, Stoltenberg SF, et al. 2003. A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology, 28:397-401.
114. Shelton RC, Manier DH, Peterson CS, et al. 1999. CyclicAMP-dependent protein kinase in subtypes of major depression and normal volunteers. Int J Neuropsychopharmacol, 2:187-92.
115. Shelton RC, Manier DH, Sulser F. 1996. cAMP-dependent protein kinase activity in major depression. Am J Psychiatry, 153:1037-42.
116. Sherman AD, Sacquitne JL, Petty F. 1982. Specificity of the learned helplessness model of depression. Pharmacol Biochem Behav, 16:449-54.
117. Shimizu E, Hashimoto K, Okamura N, et al. 2003. Alterations of serum levels of brain-derived neurotrphic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry, 54:70-5.
118. Shirayama Y, Chen ACH, Nakagawa S, et al. 2002. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci, 22:3251-61.
119. Siever LJ, Kafka MS, Targum S, et al. 1984. Platelet alpha-adrenergic binding and biochemical responsiveness in depressed patients and controls. Psychiatry Res, 11:287-302.
120. Silva AJ, Kogan JH, Frankland PW. 1998. CREB and memory. Annu Rev Neurosci, 21:127-48.
121. Siuciak JA, Lewis DR, Wiegand SJ, et al. 1996. Antidepressant-like effect of brain derived neurotrophic factor (BDNF). Pharmacol Biochem Beh, 56:131-7.
122. Skalhegg BS, Tasken K. 2000. Specificity in the cAMP/PKA signaling pathway. Differential expression, regulation, and subcellular localization of subunits of PKA. Front Biosci, 5:D678-93.
123. Sklar P, Gabriel SB, McInnis MG, et al. 2002. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry, 7:579-93.
124. Smith MA, Makino S, Kim SY, et al. 1995a. Stress increases brain-derived neurotropic factor messenger ribonucleic acid in the hypothalamus and pituitary. Endocrinology, 136:3743-50.
125. Smith MA, Makino, S, Kvetnansky R, et al. 1995b. Effects of stress on neurotrophic; factor expression in the rat brain. Ann N Y Acad Sci, 771:234-9.
126. Soares JC, Mann JJ. 1997. The anatomy of mood disorders-review of structural imaging studies. Biol Psychiatry, 41:86-106.
127. Song HJ, Poo MM. 1999. Signal transduction underlying growth cone guidance by diffusible factors. Curr Opin Neurobiol, 9:355-63.
128. Spaulding SW 1993. The ways in which hormones change cyclic adenosine 3′5′-monophosphate-dependent protein kinase subunits, and how such changes affect cell behavior. Endocr Rev, 14:632-50.
129. Spearing M. 2001. Bipolar disorder. NIH Publication No. 02-3679, Washington, DC
130. Srivastava K, Lee YN, Noguchi K, et al. 1998. The RIIβ regulatory subunit of protein kinase A binds to cAMP response element: an alternative cAMP signaling pathway. Proc Natl Acad Sci USA, 95:6687-92.
131. Steinberg RA, Agard DA. 198 1. Turnover of regulatory subunit of cyclic AMP-dependent protein kinase in S49 mouse lymphoma cells. Regulation by catalytic subunit and analogs of cyclic AMP. J Biol Chem, 256:10731-4.
132. Stewart RJ, Chen B, Dowlatshahi D, et al. 2001. Abnormalities in the cAMP signaling pathway in postmortem brain tissue from the Stanley Neuropathology Consortium. Brain Res Bull, 55:625-9.
133. Sulser F. 2002. The role of CREB and other transcription factors in the pharmacotherapy and etiology of depression. Ann Med, 34:348-56.
134. Tang WJ, Gilman AG. 1991. Type-specific regulation of adenylyl cyclase by G protein β gamma subunits. Science, 254:1500-3.
135. Tasken KA, Knutsen HK, Eikvar L, et al. 1992. Protein kinase C activation by 12-O-tetradecanoylphorbol 13-acetate modulates messenger ribonucleic acid levels for two of the regulatory subunits of 3′,5′-cyclic adenosine monophosphate-dependent protein kinases (RII alpha and RI alpha) via multiple and distinct mechanisms. Endocrinology, 130:1271-80.
136. Thoenen H. 1995. Neurotrophins and neuronal plasticity. Science, 270:593-8.
137. Thome J, Sakai N, Shin K, et al. 2000. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci, 20:4030-6.
138. Tsai SJ. 2004. Is mania caused by overactivity of central brain-derived neurotrophic factor? Med Hypotheses, 62:19-22.
139. Ueyama T, Kawai Y, Nemoto K, et al. 1997. Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain. Neurosci Res, 28:103-10.
140. Uhler MD, Chrivia JC, McKnight GS. 1986. Evidence for a second isoform. of the catalytic subunit of cAMP-dependent protein kinase. J Biol Chem, 261:15360-3.
141. Vollenweider FX, Maguire RP, Leenders KL, et al. 1998. Effects of high amphetamine dose on mood and cerebral glucose metabolism in normal volunteers using positron emission tomography (PET). Psychiatry Res, 83:149-62.
142. Wang JF, Asghari V, Rockel C, et al. 1999. Cyclic AMP responsive element binding protein phosphorylation and DNA binding is decreased by chronic lithium but not valproate treatment of SH-SY5Y neuroblastoma cells. Neuroscience, 91:771-6.
143. Wang YC, Pandey GN, Mendels J, et al. 1974. Platelet adenylate cyclase responses in depression: implications for a receptor defect. Psychopharmacologia, 36:291-300.
144. Watanabe Y, Gould E, McEwen BS. 1992. Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons. Brain Res, 588:341-5.
145. Wen Y, Anwer K, Singh SP, et al. 1992. Protein kinase A inhibits phospholipase C activity and alters protein phosphorylation in rat myometrial plasma membranes. Endocrinology, 131:1377-82.
146. Wolf S, Martinez C, Majzoub JA. 1999. Inducible binding of cyclic adenosine 3′,5′-monophosphate (cAMP)-responsive element binding protein (CREB) to a cAMP-responsive promoter in vivo. Mol Endocrinol, 13:659-69.
147. Woolley CS, Gould E, McEwen BS. 1990. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res, 531:225-31.
148. Yamada S, Yamamoto M, Ozawa H, et al. 2003. Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder. J Neural Transm, 110:671-80.
149. Young LT, Li PP, Kish SJ, et al. 1993. Cerebral cortex Gs alpha protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. J Neurochem, 61:890-8.
150. Zanardi R, Racagni G, Smeraldi E, et al. 1997. Differential effects of lithium on platelet protein phosphorylation in bipolar patients and healthy subjects. Psychopharmacology (Berl), 129:44-7.
151. Zubenko GS, Hughes HB 3rd, Maher BS, et al. 2002. Genetic linkage of region containing the CREB1 gene to depressive disorders in women from families with recurrent, early-onset, major depression. Am J Med Genet, 114:980-7.